Yes, real people have received money from the Roundup lawsuit. Tens of thousands of claimants collected compensation after Bayer agreed to one of the largest product liability settlements in American history.
The total payout across resolved cases topped $10 billion. That number sounds enormous. But the path from filing to getting a check is not always quick or simple.
In this article, you’ll learn who actually received money, how much individual claimants collected, what cancers qualify, and whether you can still file a claim in 2026.
One fact that surprises most people: not every claimant in the Bayer settlement received the same amount. Payments ranged from tens of thousands to over $100,000, depending on several factors specific to each case.
Has Anyone Received Money From the Roundup Lawsuit?
Yes, thousands of people have received money from the Roundup lawsuit. Bayer reached a landmark settlement agreement starting in June 2020, covering approximately 125,000 resolved cases at that time. Payments began flowing to eligible claimants after that agreement was finalized.
The settlement was not one single check to everyone. It was structured as a tiered compensation program managed through a claims administrator process. Each claimant’s payout was calculated individually.
Bayer set aside roughly $8.8 billion to $9.6 billion specifically for these resolved cases. A separate allocation of up to $1.25 billion was earmarked for future litigation, showing the company anticipated more claims beyond the initial wave.
Real people with documented non-Hodgkin lymphoma diagnoses and verifiable Roundup exposure were the ones who saw payments. Those with stronger medical records, longer exposure histories, and serious diagnoses received the largest amounts.
| Settlement Wave | Cases Covered | Bayer Allocation |
|---|---|---|
| Initial 2020 Agreement | ~125,000 cases | $8.8B to $9.6B |
| Future Claim Fund | Ongoing wave litigation | Up to $1.25B |
| Remaining Litigation | Still active 2026 | TBD per case resolution |
The short answer is yes. The longer answer is that receiving money required meeting strict eligibility criteria, submitting documented proof, and waiting through the claims process.
How Much Did Roundup Victims Get Paid?
Individual Roundup victims received settlements ranging from approximately $5,000 to over $250,000 depending on their diagnosis, exposure history, and case specifics. A small number of bellwether trial plaintiffs who went to full jury verdicts received significantly more.
The average reported settlement in the mass resolution was between $150,000 and $200,000 for qualifying cases with strong evidence. Cases with weaker documentation or shorter exposure periods landed on the lower end.
Three early trial plaintiffs set the tone for how juries viewed Roundup cases. Dewayne Johnson, a school groundskeeper diagnosed with terminal non-Hodgkin lymphoma, received an initial jury verdict of $289 million in 2018. That was later reduced to $78 million on appeal. Edwin Hardeman was awarded $80 million. The Pilliod couple received $2 billion initially, later reduced to $87 million combined.
These trial verdicts were outliers. Most settled claimants received far less. But the jury awards showed what was at stake and pushed Bayer to settle.
| Claimant Type | Approximate Payment Range |
|---|---|
| Strong diagnosis, long exposure | $150,000 to $250,000+ |
| Moderate case strength | $50,000 to $150,000 |
| Weaker documentation | $5,000 to $50,000 |
| Bellwether trial verdicts | $78M to $87M (post-reduction) |
Attorneys’ fees typically reduced the net payment to each claimant by 33% to 40%. That is standard in contingency-fee mass tort cases.
What Are the Roundup Lawsuit Settlement Amounts?
The Roundup lawsuit settlement amounts varied widely across the litigation. The total resolved settlement pool was approximately $10.9 billion, covering the initial 125,000 cases and additional claims resolved in subsequent rounds.
Think of it like an insurance pool. Bayer deposited a large sum. Claims administrators divided it based on each case’s point value. Cases earned points based on cancer severity, age at diagnosis, exposure duration, and other documented factors.
The point system meant two people with the same cancer diagnosis could receive very different amounts based on how long they used Roundup, whether they had other potential risk factors, and how well-documented their medical history was.
Jury trial verdicts that were not settled gave a different picture. Those verdicts exceeded billions in aggregate but were almost always reduced significantly on post-trial motions.
| Settlement Component | Amount |
|---|---|
| Bayer total settlement commitment | ~$10.9 billion |
| Resolved cases (2020 wave) | ~$8.8B to $9.6B |
| Future litigation reserve | ~$1.25B |
| Individual claimant average (reported) | ~$150,000 to $200,000 |
What the settlement amounts do not reflect is the emotional and physical cost to the people who filed. For many, the compensation came after years of cancer treatment, lost income, and significant suffering.
What Is the Roundup Settlement Payout Per Person?
The Roundup settlement payout per person was not a fixed number. Each claimant received an individualized amount calculated through a point-based valuation system used by the claims administrator.
Points were assigned based on:
- Diagnosis type (non-Hodgkin lymphoma subtype and severity)
- Age at diagnosis (younger plaintiffs with more life expectancy often received more)
- Exposure duration (years and frequency of Roundup use)
- Causation strength (how directly evidence linked Roundup to the diagnosis)
- Other cancer risk factors (pre-existing conditions could reduce the score)
The highest-scoring cases, those with strong diagnosis documentation and long exposure histories, received payouts in the $200,000 to $300,000 range before attorney fees. Median payouts for typical resolved cases landed closer to $100,000 to $150,000 before fees.
After attorney fees of 33% to 40%, most individual claimants netted between $60,000 and $120,000 in actual take-home money.
Some claimants with very weak documentation and short exposure periods received as little as $5,000 to $15,000. Cases that did not meet the full eligibility threshold were sometimes dismissed or received minimal compensation.
Key Takeaway: The payout per person depended heavily on the strength of medical evidence and the duration of Roundup exposure. No two cases were exactly alike in the settlement calculation.
How Does the Bayer Roundup Settlement Fund Work?
The Bayer Roundup settlement fund is a structured pool of money set aside by Bayer AG specifically to resolve Roundup-related cancer claims. Bayer funded the pool in stages rather than depositing the entire amount upfront.
Bayer announced its $10.9 billion settlement commitment in June 2020. This covered approximately 125,000 cases that were either pending in courts or in the claims submission pipeline at that time.
The fund was not administered by Bayer directly. An independent claims administrator handled the review, scoring, and distribution process. Claimants submitted their documentation to the administrator, not to Bayer’s legal team.
Here is how the fund process worked in sequence:
- Step 1: Claimant submits claim with medical records and exposure documentation.
- Step 2: Claims administrator reviews and assigns a point score.
- Step 3: Point score determines the claimant’s tier and base payment amount.
- Step 4: Attorney fees are deducted from the gross settlement.
- Step 5: Net payment is disbursed to the claimant.
Bayer also created a separate $1.25 billion allocation for future Roundup cases not yet filed or resolved at the time of the 2020 agreement. That reserve was intended to handle new cases expected to emerge from ongoing litigation.
What Is the Roundup Lawsuit Average Payout?
The Roundup lawsuit average payout across the settled cases was approximately $160,000 gross per claimant before attorney fees, based on figures cited by legal analysts reviewing the settlement structure. Net payouts after fees averaged closer to $100,000 to $110,000.
That average, however, is pulled up significantly by the highest-value cases. The median payment for a typical qualifying claimant was more likely in the $50,000 to $100,000 range.
Comparing this to other large mass tort settlements gives context. The talcum powder lawsuits have seen individual payouts from $100,000 to $1 million for ovarian cancer cases. Opioid settlements distributed through state governments paid individuals very little directly. The Roundup settlement, by contrast, paid individual plaintiffs directly, which made it unusually impactful per person.
| Settlement Comparison | Average Individual Payout |
|---|---|
| Roundup (Bayer) | ~$100,000 to $160,000 |
| Talcum Powder (J&J) | ~$100,000 to $1M+ |
| Camp Lejeune Water | Ranges widely, still processing |
| Opioid (state-level) | Very little to individuals directly |
The key word is “average.” Your actual potential payout depends entirely on your specific case. Cases at the high end of the scale had terminal diagnoses, decades of Roundup use, and minimal competing risk factors.
Key Takeaway: The Roundup average payout was around $100,000 to $160,000 gross, but individual amounts varied dramatically based on case strength.
Did Roundup Settlement Checks Actually Go Out?
Yes, Roundup settlement checks have gone out. Payments began processing after the June 2020 settlement agreement was executed and the claims review process was completed for individual claimants. Many plaintiffs in the initial wave received payments during 2021 and 2022.
The payment timeline was not instant. After agreeing to settle, each claimant’s case still went through the documentation review and point-scoring process. That review took months for most claimants.
Some claimants experienced delays due to incomplete medical records, disputes over exposure documentation, or issues with their individual agreements. Those cases took longer to process, sometimes extending into 2023 and 2024.
As of 2026, some cases remain in dispute or are part of newer litigation waves that have not yet settled. Those claimants have not yet received checks. The litigation is not fully closed.
| Payment Phase | Approximate Timing |
|---|---|
| Settlement agreement announced | June 2020 |
| Claims review and scoring begins | Late 2020 |
| First wave payments distributed | 2021 to 2022 |
| Delayed or disputed cases resolved | 2022 to 2024 |
| New wave litigation (2026 active) | Payments TBD |
If you filed and have not received payment, it may mean your case is still in review, was part of a newer filing wave, or requires additional documentation before it can be processed.
What Is the Roundup Lawsuit Payout Timeline?
The Roundup lawsuit payout timeline spans from 2018 to the present, with the bulk of resolved payments occurring between 2021 and 2024. New claims filed in 2025 and 2026 are operating on a separate and later timeline.
The timeline broke into distinct phases:
- 2015 to 2018: Individual lawsuits filed. IARC classifies glyphosate as “probably carcinogenic” in 2015. MDL No. 2741 consolidated in 2016 in Northern California.
- 2018 to 2019: Three bellwether trials result in massive jury verdicts.
- 2020: Bayer announces $10.9 billion settlement covering approximately 125,000 cases.
- 2020 to 2021: Individual claimants reviewed and scored by claims administrator.
- 2021 to 2022: Majority of initial wave payments distributed to eligible claimants.
- 2022 to 2024: Delayed, disputed, or supplemental cases resolved and paid.
- 2025 to 2026: New litigation wave active. Cases from newer claimants moving through courts.
Think of this like a hospital with multiple emergency rooms. The first wave of patients was treated and discharged. A second wave is still being assessed. You might be in the waiting room if you filed recently.
Key Takeaway: Most first-wave claimants received payment between 2021 and 2024. People filing in 2025 or 2026 are on a much later timeline that has not yet reached the payment stage.
What Is the Roundup Cancer Lawsuit Eligibility Criteria?
Roundup cancer lawsuit eligibility is based on three primary requirements: a qualifying cancer diagnosis, documented exposure to Roundup or glyphosate-based herbicides, and a plausible link between the two.
These three elements form the foundation of every successful Roundup claim. Missing any one of them typically disqualifies a claim from the settlement or litigation process.
Diagnosis requirement: The primary qualifying diagnosis is non-Hodgkin lymphoma (NHL). Some related blood cancers and lymphomas may also qualify depending on the specific case and legal team evaluation.
Exposure requirement: You must have used Roundup or another glyphosate herbicide directly, meaning you mixed, applied, or were regularly near the product. Residential users, farmers, landscapers, golf course workers, and groundskeepers have all qualified.
Causal link requirement: Your legal team will evaluate whether your cancer diagnosis fits the medical and scientific evidence connecting glyphosate to NHL. This is assessed using medical records, expert witnesses, and published research.
| Eligibility Factor | Requirement |
|---|---|
| Primary qualifying cancer | Non-Hodgkin Lymphoma (NHL) |
| Exposure type | Direct use or close proximity to Roundup/glyphosate |
| Exposure duration | Typically multiple years (stronger case with 5+ years) |
| Diagnosis timing | Must have received diagnosis before or after filing |
| Documentation | Medical records, purchase receipts, work records |
The strength of your eligibility is not just a yes or no. It exists on a spectrum that directly affects how much you may receive.
Who Qualifies for the Roundup Lawsuit in 2026?
People who qualify for the Roundup lawsuit in 2026 are those diagnosed with non-Hodgkin lymphoma or certain related blood cancers who also have documented history of Roundup or glyphosate herbicide exposure. New cases are still being accepted.
The litigation did not end with Bayer’s 2020 settlement. New claimants continue to file, and Bayer continues to defend cases in court. A Supreme Court appeal attempt by Bayer was rejected, meaning state court claims can move forward.
Who can still file in 2026:
- People diagnosed with NHL who used Roundup but have not yet filed
- Family members filing on behalf of a deceased loved one (wrongful death claim)
- People who filed but were excluded from the initial settlement wave
- People whose diagnosis occurred after the first settlement cutoff
| Qualifying Person | Situation |
|---|---|
| NHL patient who used Roundup | Primary qualifying claimant |
| Deceased person’s estate | Wrongful death or survival claim |
| Previously excluded claimant | May be eligible in new wave |
| Recently diagnosed patient | Can file in 2026 within statute of limitations |
One thing people underestimate is the statute of limitations. You typically have 2 to 3 years from when you knew or should have known about the Roundup-cancer connection to file. That clock varies by state.
What Cancers Qualify for the Roundup Lawsuit?
Non-Hodgkin lymphoma is the primary cancer that qualifies for the Roundup lawsuit. It is the diagnosis most directly supported by scientific and legal evidence connecting glyphosate exposure to cancer development.
Non-Hodgkin lymphoma is not one cancer. It is a family of over 60 types of lymphoma originating in the lymphatic system. Several NHL subtypes have been seen in Roundup cases.
Qualifying cancer types include:
- Diffuse large B-cell lymphoma (DLBCL) – most common NHL subtype in Roundup cases
- Follicular lymphoma
- Mantle cell lymphoma
- B-cell lymphoma
- T-cell lymphoma (some cases)
- Chronic lymphocytic leukemia/Small lymphocytic lymphoma (CLL/SLL)
- Multiple myeloma (evaluated case by case)
| Cancer Type | Qualifying Status |
|---|---|
| Non-Hodgkin Lymphoma (all subtypes) | Primary qualifying diagnosis |
| Diffuse Large B-Cell Lymphoma | Strongly qualifying |
| Follicular Lymphoma | Qualifying |
| Multiple Myeloma | Evaluated individually |
| Hodgkin Lymphoma | Generally not qualifying |
| Leukemia (most forms) | Evaluated case by case |
Hodgkin lymphoma is biologically different from NHL and has not been a standard qualifying diagnosis in Roundup litigation. If you have a lymphoma diagnosis, a legal evaluation can determine which category your specific diagnosis falls into.
Key Takeaway: Non-Hodgkin lymphoma and its many subtypes are the core qualifying diagnoses. If your diagnosis is related to the lymphatic system, your case is worth a legal review even if you are unsure it qualifies.
How Does the Roundup Non-Hodgkin Lymphoma Lawsuit Work?
The Roundup non-Hodgkin lymphoma lawsuit works by establishing that your NHL diagnosis was caused or materially contributed to by your exposure to Roundup’s active ingredient, glyphosate. This is a product liability claim against Bayer/Monsanto.
The scientific foundation comes from the International Agency for Research on Cancer (IARC), which classified glyphosate as “Group 2A: probably carcinogenic to humans” in 2015. That classification, based on epidemiological studies and animal research, became the cornerstone of every Roundup cancer lawsuit.
The legal theory is that Monsanto knew about the cancer risk, failed to warn consumers, and continued marketing Roundup as safe. That failure-to-warn argument drove the early jury verdicts and pushed Bayer to settle.
In practice, your lawsuit follows these steps:
- Hire a mass tort attorney with Roundup experience.
- Gather medical records documenting your NHL diagnosis.
- Document exposure history through receipts, work records, or testimony.
- Attorney files your individual complaint or joins the MDL.
- Case evaluated by claims administrator or prepared for trial.
- Settlement or verdict determines your payout.
The MDL, or multidistrict litigation, in the Northern District of California has been the central hub for federal Roundup cases. State courts across the country handle cases filed under individual state law.
What Is the Glyphosate Cancer Lawsuit Settlement?
The glyphosate cancer lawsuit settlement refers to the broader legal resolution covering all claims that glyphosate, the active chemical in Roundup, caused cancer in exposed individuals. Bayer inherited this liability when it acquired Monsanto in 2018 for $63 billion.
Glyphosate is one of the most widely used herbicides in the world. It was introduced by Monsanto in 1974 under the Roundup brand. For decades, it was considered one of the safer herbicides available. The IARC’s 2015 reclassification changed everything legally.
The settlement is technically a product liability resolution. Bayer has consistently denied that glyphosate causes cancer, even while paying out billions to resolve claims. This legal maneuvering is standard. Companies often settle to avoid jury risk without admitting liability.
| Glyphosate Lawsuit Facts | Details |
|---|---|
| Herbicide introduced | 1974 (Monsanto) |
| IARC “probably carcinogenic” classification | 2015 |
| Bayer acquires Monsanto | 2018 |
| First bellwether trial verdict | August 2018 (Dewayne Johnson) |
| Total settlement announced | June 2020 |
| Settlement amount | ~$10.9 billion |
The glyphosate lawsuit is distinct from the branded Roundup lawsuit in one way. People exposed to other glyphosate-based herbicides (not just Roundup) may also have claims, depending on the specific product and their state’s laws.
What Is the Bayer Roundup Settlement Update for 2026?
The Bayer Roundup settlement update for 2026 shows that litigation is ongoing, with new cases continuing to be filed and litigated in both federal and state courts. Bayer has not achieved a full and final closure of Roundup liability.
Bayer attempted to get the U.S. Supreme Court to block state court Roundup claims. The Supreme Court declined to hear the case in 2022, leaving state court claims fully active. That decision opened the door for continued litigation through 2025 and into 2026.
Bayer set aside additional reserves on its financial statements to cover ongoing Roundup liability. The company’s 2023 and 2024 annual reports reflected continued Roundup-related legal costs, signaling that the litigation is far from finished.
Key 2026 developments to know:
- New individual cases are still being filed in state courts.
- Bayer continues defending cases that do not settle.
- Appeals from earlier verdicts are still working through appellate courts.
- Newer claimants who file in 2026 should expect a multi-year process before any payment.
- Bayer has not developed a new global settlement to cover all remaining claims.
Bayer’s stock price has taken significant hits from ongoing Roundup liability. That financial pressure continues to push the company toward negotiated resolutions where possible.
Key Takeaway: The Roundup litigation is still very much alive in 2026. Bayer has not closed the book on this liability, and new claimants can still pursue compensation.
What Is the Roundup Lawsuit Filing Deadline in 2026?
The Roundup lawsuit filing deadline in 2026 depends on your state’s statute of limitations, which typically gives claimants 2 to 3 years from the date they discovered or should have discovered the connection between Roundup and their cancer diagnosis.
There is no single universal deadline for all Roundup cases. Each state has its own personal injury statute of limitations. Most fall between 2 and 3 years from the “discovery date,” meaning when you learned your cancer may be linked to glyphosate exposure.
If your diagnosis was recent, your clock may still be running. If you were diagnosed several years ago, your deadline may be closer than you think.
| State Statute of Limitations | Typical Timeframe |
|---|---|
| California | 2 years from discovery |
| Texas | 2 years from diagnosis/discovery |
| Florida | 2 years from discovery (amended 2023) |
| New York | 3 years from discovery |
| Illinois | 2 years from discovery |
| Federal MDL filings | Subject to tolling agreements |
The MDL court in California used tolling agreements to pause the statute of limitations for certain cases while litigation was coordinated. But that protection is not automatic for new filers.
The bottom line: if you believe you have a Roundup claim, waiting costs you options. Every month matters when statutes of limitations are involved.
How to File a Roundup Lawsuit Claim in 2026
Filing a Roundup lawsuit claim in 2026 starts with gathering your medical records, confirming your NHL diagnosis, and connecting with a mass tort attorney who handles active Roundup litigation. The process is still open for qualifying claimants.
Here is the step-by-step path:
Step 1: Confirm your diagnosis. You need documented medical records showing NHL or a related qualifying cancer. Your oncologist or treating physician’s records are essential.
Step 2: Document your Roundup exposure. Collect anything that proves you used Roundup: purchase records, photos, work logs, testimony from coworkers or family, or employment records showing landscaping or agricultural work.
Step 3: Find a qualified mass tort attorney. Most Roundup attorneys work on contingency, meaning you pay nothing unless you win. Look for firms with specific Roundup or glyphosate case experience.
Step 4: Submit your information for case evaluation. The attorney will review your medical and exposure history to assess your case strength and potential value.
Step 5: Your case is filed or joined. Depending on your state and situation, your attorney will file in state court or seek to join the federal MDL.
Step 6: Negotiation or litigation. Your case either resolves through settlement negotiation or proceeds to trial.
| Filing Step | What It Involves |
|---|---|
| Medical documentation | NHL diagnosis records from treating physician |
| Exposure documentation | Purchase receipts, work logs, employer records |
| Attorney selection | Contingency-fee mass tort attorney |
| Case evaluation | Attorney reviews case strength and files |
| Resolution | Settlement negotiation or jury trial |
The process takes time. Most new cases filed in 2026 should realistically expect a 1 to 3 year timeline before any payment, depending on how Bayer handles new litigation waves.
Frequently Asked Questions
Has anyone actually received money from the Roundup lawsuit?
Yes, thousands of people have received money from the Roundup lawsuit.
Bayer resolved approximately 125,000 cases through its 2020 settlement agreement, with payments distributed primarily between 2021 and 2024.
New cases filed in 2025 and 2026 are still working through the litigation process and have not yet reached the payment stage.
How much money do Roundup lawsuit claimants typically receive?
Roundup claimants typically receive between $50,000 and $200,000 after attorney fees.
The gross settlement before fees averaged approximately $150,000 to $160,000 for qualifying cases with strong documentation.
Individual amounts vary based on cancer severity, exposure duration, and the strength of medical evidence.
Can I still file a Roundup lawsuit claim in 2026?
Yes, you can still file a Roundup lawsuit claim in 2026 if your state’s statute of limitations has not expired.
Most states give you 2 to 3 years from your discovery date to file.
New cases are still being accepted by mass tort attorneys, and Bayer is still actively defending and settling claims.
What type of cancer qualifies for a Roundup settlement?
Non-Hodgkin lymphoma (NHL) is the primary qualifying cancer for the Roundup lawsuit.
Multiple NHL subtypes qualify, including diffuse large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma.
Some related blood cancers like multiple myeloma may be evaluated on a case-by-case basis.
How long does it take to receive a Roundup lawsuit payout?
For new cases filed in 2026, realistically expect 1 to 3 years before any payment is received.
The timeline depends on whether your case settles or goes to trial, and how quickly your documentation is processed.
Claimants in the original 2020 settlement wave typically waited 12 to 24 months from signing their settlement agreements to receiving payment.
The Roundup fight is not over. Real payments went out. New claims are still viable.
Bayer paid billions to resolved claimants. That money reached real people dealing with real cancer diagnoses. The payment system worked, even if it was slow and complicated.
If you haven’t filed yet and believe you qualify, the window is still open in 2026. But it won’t stay open indefinitely.
Gather your medical records. Document your exposure history. Connect with a mass tort attorney who knows this case. That is the practical path from here.
